0001142750 false 0001142750 2022-06-10 2022-06-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares







Date of report (Date of earliest event reported): June 10, 2022


(Exact name of registrant as specified in its charter)
Delaware 001-16753 06-1500476
(State or other jurisdiction
of incorporation)
File Number)
(I.R.S. Employer
Identification No.)

8840 Cypress Waters Boulevard, Suite 300

Dallas, Texas 75019

(Address of principal executive offices) (Zip Code)
(866) 871-8519
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)  

Name of each exchange

on which registered

Common Stock, par value $0.01 per share   AMN   NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 8.01.Other Events.


On June 15, 2022, AMN Healthcare Services, Inc. (the "Company") issued a press release announcing an increase to its share repurchase program. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.


Item 9.01.Financial Statements and Exhibits.


(d) Exhibits.


Exhibit No.   Description
99.1   Press Release issued by the Company on June 15, 2022

Cover Page Interactive Data File (embedded within the Inline XBRL document)








Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  AMN Healthcare Services, Inc.  

Date: June 15, 2022

By: /s/ Susan R. Salka  
    Susan R. Salka  
    President & Chief Executive Officer  








AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program


DALLAS, June 15, 2022 - The Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (NYSE: AMN, the “Company”) authorized an additional $250 million under the Company’s repurchase program for the company’s common stock (the “Increased Company Repurchase Program”).


The Company has repurchased 6.76 million shares of common stock at an average price of $77.44 per share excluding broker’s fees, resulting in an aggregate purchase price of $523.5 million, under the Share Repurchase Program since first authorized in 2016. Since the beginning of the second quarter, the Company has repurchased 1.88 million shares at an average price of $92.65 for $173.8 million. The total remaining dollar value of common stock that may be repurchased under the Increased Company Repurchase Program is approximately $326.3 million.


The Increased Company Repurchase Program does not require the purchase of any minimum number of shares, does not have an expiration date, and may be suspended or discontinued at any time. The amount and timing of the purchases will depend on a number of factors including the price of the Company’s shares, trading volume, Company performance, Company liquidity, general economic and market conditions and other factors that the Company’s management believes are relevant.


Repurchases may be made from cash on hand, free cash flow generated from the Company’s business or from the Company’s credit facilities. Repurchases may also be made pursuant to one or more plans established pursuant to Rule 10b5-1 under the Exchange Act, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading restrictions.


About AMN Healthcare 
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the nation. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry. For more information about AMN Healthcare, visit www.amnhealthcare.com 


Investor Contact 
Randle Reece 
Director, Investor Relations 
AMN Healthcare 
(866) 861-3229